Jelonek M T, Classon B J, Hudson P J, Margulies D H
Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
J Immunol. 1998 Mar 15;160(6):2809-14.
MHC class I molecules (MHC-I) display peptides from the intracellular pool at the cell surface for recognition by T lymphocytes bearing alphabeta TCR. Although the activation of T cells is controlled by the interaction of the TCR with MHC/peptide complexes, the degree and extent of the activation is influenced by the binding in parallel of the CD8 coreceptor with MHC-I. In the course of quantitative evaluation of the binding of purified MHC-I to engineered CD8, we observed that peptide-deficient H-2Ld (MHC-I) molecules bound with moderate affinity (Kd = 7.96 x 10(-7) M), but in the presence of H-2Ld-binding peptides, no interaction was observed. Examination of the amino terminal sequences of CD8alpha and beta chains suggested that H-2Ld might bind these protein termini via its peptide binding cleft. Using both competition and real-time direct assays based on surface plasmon resonance, we detected binding of empty H-2Ld to synthetic peptides representing these termini. These results suggest that some MHC molecules are capable of binding the amino termini of intact cell surface proteins through their binding groove and provide alternative explanations for the observed binding of MHC molecules to a variety of cell surface receptors and coreceptors.
MHC I类分子(MHC-I)在细胞表面展示来自细胞内池的肽段,以供携带αβ TCR的T淋巴细胞识别。虽然T细胞的激活由TCR与MHC/肽复合物的相互作用控制,但激活的程度和范围受CD8共受体与MHC-I平行结合的影响。在对纯化的MHC-I与工程化CD8结合进行定量评估的过程中,我们观察到缺乏肽段的H-2Ld(MHC-I)分子以中等亲和力(Kd = 7.96 x 10(-7) M)结合,但在存在H-2Ld结合肽的情况下,未观察到相互作用。对CD8α和β链氨基末端序列的检查表明,H-2Ld可能通过其肽结合裂隙与这些蛋白质末端结合。使用基于表面等离子体共振的竞争和实时直接测定法,我们检测到空的H-2Ld与代表这些末端的合成肽的结合。这些结果表明,一些MHC分子能够通过其结合槽结合完整细胞表面蛋白的氨基末端,并为观察到的MHC分子与多种细胞表面受体和共受体的结合提供了其他解释。